 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Schilke Tobin
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-01-26 Sale | 2017-01-30 9:38 pm | Achaogen Inc | AKAO | Schilke Tobin CFO | 955 | $16.78 | $16,025 | 26,045 (Direct) | View |
| 2017-06-12 Sale | 2017-06-14 7:39 pm | Achaogen Inc | AKAO | Schilke Tobin CFO | 2,066 | $21.53 | $44,481 | 40,119 (Direct) | View |
| 2018-02-21 Sale | 2018-02-23 8:38 pm | Achaogen Inc | AKAO | Schilke Tobin CFO | 1,108 | $10.67 | $11,822 | 40,185 (Direct) | View |
| 2018-06-11 Sale | 2018-06-13 5:03 pm | Achaogen Inc | AKAO | Schilke Tobin CFO | 2,087 | $11.95 | $24,940 | 47,186 (Direct) | View |
| 2018-06-26 Sale | 2018-06-28 4:20 pm | Achaogen Inc | AKAO | Schilke Tobin CFO | 298 | $9.59 | $2,858 | 47,748 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-07-05 Option Award | 2016-07-06 8:34 pm | N/A N/A | Achaogen Inc | AKAO | Schilke Tobin CFO | 27,000 | $0 | 26,000 (Direct) | View |
| 2016-07-05 Option Award | 2016-07-06 8:34 pm | N/A 2026-07-05 | Achaogen Inc | AKAO | Schilke Tobin CFO | 100,000 | $4.09 | 26,000 (Direct) | View |
| 2016-07-05 Option Award | 2016-07-06 8:34 pm | N/A 2026-07-05 | Achaogen Inc | AKAO | Schilke Tobin CFO | 26,000 | $4.09 | 26,000 (Direct) | View |
| 2017-02-22 Option Award | 2017-02-24 8:13 pm | N/A N/A | Achaogen Inc | AKAO | Schilke Tobin CFO | 13,500 | $0 | 12,600 (Direct) | View |
| 2017-02-22 Option Award | 2017-02-24 8:13 pm | N/A 2026-02-22 | Achaogen Inc | AKAO | Schilke Tobin CFO | 50,400 | $23.62 | 12,600 (Direct) | View |
| 2017-02-22 Option Award | 2017-02-24 8:13 pm | N/A 2026-02-22 | Achaogen Inc | AKAO | Schilke Tobin CFO | 12,600 | $23.62 | 12,600 (Direct) | View |
| 2018-02-08 Option Award | 2018-05-15 6:33 pm | N/A N/A | Achaogen Inc | AKAO | Schilke Tobin CFO | 6,880 | $0 | 32,000 (Direct) | View |
| 2018-02-08 Option Award | 2018-05-15 6:33 pm | N/A 2028-02-08 | Achaogen Inc | AKAO | Schilke Tobin CFO | 32,000 | $10.64 | 32,000 (Direct) | View |
| 2018-06-26 Option Award | 2018-06-28 4:20 pm | N/A N/A | Achaogen Inc | AKAO | Schilke Tobin CFO | 860 | $0 | 47,748 (Direct) | View |
| 2018-06-26 Option Award | 2018-06-28 4:20 pm | N/A 2028-02-08 | Achaogen Inc | AKAO | Schilke Tobin CFO | 4,000 | $10.64 | 47,748 (Direct) | View |
| 2018-11-05 Option Award | 2018-11-07 8:31 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 18,000 | $0 | 100,000 (Direct) | View |
| 2018-11-05 Option Award | 2018-11-07 8:31 pm | N/A 2028-11-04 | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 100,000 | $24.96 | 100,000 (Direct) | View |
| 2019-01-24 Option Award | 2019-01-25 9:00 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 5,000 | $0 | 30,000 (Direct) | View |
| 2019-01-24 Option Award | 2019-01-25 9:00 pm | N/A 2029-01-23 | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 30,000 | $17.23 | 30,000 (Direct) | View |
| 2019-06-28 Other | 2019-07-02 9:16 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 923 | $11.02 | 23,923 (Direct) | View |
| 2019-12-15 Tax Withholding | 2019-12-17 7:57 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 1,556 | $15.99 | 22,367 (Direct) | View |
| 2019-12-31 Other | 2020-01-03 6:42 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 504 | $10.82 | 22,871 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-24 8:21 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 16,500 | $0 | 97,500 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-24 8:21 pm | N/A 2030-01-22 | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 97,500 | $22.32 | 97,500 (Direct) | View |
| 2020-02-15 Tax Withholding | 2020-02-19 8:21 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 576 | $25.33 | 38,795 (Direct) | View |
| 2020-06-30 Other | 2020-07-02 8:18 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 763 | $13.8 | 39,558 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 8:32 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 15,750 | $0 | 49,862 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-02 8:32 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 5,446 | $25.14 | 49,862 (Direct) | View |
| 2020-12-15 Tax Withholding | 2020-12-22 8:39 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 1,556 | $26.75 | 48,306 (Direct) | View |
| 2020-12-31 Other | 2021-01-04 8:02 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 493 | $21.36 | 48,799 (Direct) | View |